CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression

• Published in: Biomolecules (Basel, Switzerland) Vol. 14; no. 8; p. 914
• Main Authors: Baker, Carly E, Marta, Aaron G, Zimmerman, Nathan D, Korade, Zeljka, Mathy, Nicholas W, Wilton, Delaney, Simeone, Timothy, Kochvar, Andrew, Kramer, Kenneth L, Stessman, Holly A. F, Shibata, Annemarie
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2024; MDPI
• Subjects: Axonogenesis; Body size; Brain; brain development; Carnitine; Carnitine palmitoyltransferase; Congenital diseases; CPT2 deficiency; Danio rerio; Disease; Embryos; Enzymes; Epilepsy; Ethylenediaminetetraacetic acid; Fatty acids; Gene expression; Gene regulation; Genes; Genetic disorders; Hyperactivity; Instrument industry; Mental disorders; Metabolic disorders; Mutation; Nervous system diseases; Neurodegenerative diseases; Neurodevelopmental disorders; Oxidation; Palmitoyltransferase; Pharmaceutical industry; Protocol; Schizophrenia; Scientific equipment and supplies industry; seizure-like activity; Structure-function relationships; Swimming behavior; zebrafish; β-oxidation; California; United States; Massachusetts; Japan; Germany; United States > US
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom14080914

Carnitine palmitoyltransferase 2 (CPT2) is an inner mitochondrial membrane protein of the carnitine shuttle and is involved in the beta-oxidation of long chain fatty acids. Beta-oxidation provides an alternative pathway of energy production during early development and starvation. CPT2 deficiency is a genetic disorder that we recently showed can be associated with schizophrenia. We hypothesize that CPT2 deficiency during early brain development causes transcriptional, structural, and functional abnormalities that may contribute to a CNS environment that is susceptible to the emergence of schizophrenia. To investigate the effect of CPT2 deficiency on early vertebrate development and brain function, CPT2 was knocked down in a zebrafish model system. CPT2 knockdown resulted in abnormal lipid utilization and deposition, reduction in body size, and abnormal brain development. Axonal projections, neurotransmitter synthesis, electrical hyperactivity, and swimming behavior were disrupted in CPT2 knockdown zebrafish. RT-qPCR analyses showed significant increases in the expression of schizophrenia-associated genes in CPT2 knockdown compared to control zebrafish. Taken together, these data demonstrate that zebrafish are a useful model for studying the importance of beta-oxidation for early vertebrate development and brain function. This study also presents novel findings linking CPT2 deficiency to the regulation of schizophrenia and neurodegenerative disease-associated genes.